I had the opportunity to speak at the 29th AVC General Assembly held in Utrecht, the Netherlands, about the issue of shortages of veterinary medicines, which has emerged as a post-COVID issue.
It was a very meaningful opportunity to discuss the issue not only with consultants from each country, but also with Dr. Schalansky of the EU (European Community) EMA (European Medicines Agency).
